| UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses DS Chandrashekar, B Bashel, SAH Balasubramanya, CJ Creighton, ... Neoplasia 19 (8), 649-658, 2017 | 5305 | 2017 |
| UALCAN: An update to the integrated cancer data analysis platform DS Chandrashekar, SK Karthikeyan, PK Korla, H Patel, AR Shovon, ... Neoplasia 25, 18-27, 2022 | 1424 | 2022 |
| Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers F Chen, DS Chandrashekar, S Varambally, CJ Creighton Nature communications 10 (1), 1-15, 2019 | 471 | 2019 |
| Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior SK Bandari, A Purushothaman, VC Ramani, GJ Brinkley, ... Matrix Biology 65, 104-118, 2018 | 241 | 2018 |
| Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways Y Zhang, F Chen, DS Chandrashekar, S Varambally, CJ Creighton Nature Communications 13 (1), 1-19, 2022 | 146 | 2022 |
| Ferritin light chain confers protection against sepsis-induced inflammation and organ injury S Bolisetty, A Zarjou, L Black, KR McCullough, TD Hull, R Boddu, ... Frontiers in immunology 10, 131, 2019 | 89 | 2019 |
| Endometrial receptivity: a revisit to functional genomics studies on human endometrium and creation of HGEx-ERdb SR Bhagwat, DS Chandrashekar, R Kakar, S Davuluri, AK Bajpai, ... PLoS One 8 (3), e58419, 2013 | 83 | 2013 |
| Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer A Hanna, BJ Metge, SK Bailey, D Chen, DS Chandrashekar, ... Oncoimmunology 8 (3), 1548241, 2019 | 81 | 2019 |
| Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancer BVSK Chakravarthi, MT Goswami, SS Pathi, M Dodson, ... The Prostate 78 (9), 693-694, 2018 | 75 | 2018 |
| MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer BVSK Chakravarthi, MT Goswami, SS Pathi, AD Robinson, M Cieślik, ... Oncogene 35 (49), 6330, 2016 | 64 | 2016 |
| miR-34a regulates expression of the stathmin-1 oncoprotein and prostate cancer progression BVSK Chakravarthi, DS Chandrashekar, S Agarwal, ... Molecular Cancer Research 16 (7), 1125-1137, 2018 | 63 | 2018 |
| Large‐scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival V Vantaku, SR Donepudi, DWB Piyarathna, CS Amara, CR Ambati, ... Cancer 125 (6), 921-932, 2019 | 60 | 2019 |
| A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression BVSK Chakravarthi, MDCR Pena, S Agarwal, DS Chandrashekar, ... Neoplasia 20 (9), 894-904, 2018 | 58 | 2018 |
| Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancer BVSK Chakravarthi, MT Goswami, SS Pathi, M Dodson, ... The Prostate 77 (1), 10-21, 2017 | 58 | 2017 |
| TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status S Agarwal, M Behring, HG Kim, DS Chandrashekar, BVSK Chakravarthi, ... Molecular oncology 14 (12), 3007-3029, 2020 | 47 | 2020 |
| PAICS, a purine nucleotide metabolic enzyme, is involved in tumor growth and the metastasis of colorectal cancer S Agarwal, BVSK Chakravarthi, M Behring, HG Kim, DS Chandrashekar, ... Cancers 12 (4), 772, 2020 | 46 | 2020 |
| PRDM16 suppresses HIF-targeted gene expression in kidney cancer A Kundu, H Nam, S Shelar, DS Chandrashekar, G Brinkley, S Karki, ... Journal of Experimental Medicine 217 (6), 2020 | 44 | 2020 |
| DCZ0415, a small‐molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β‐catenin pathway in colorectal cancer S Agarwal, F Afaq, P Bajpai, HG Kim, A Elkholy, M Behring, ... Molecular oncology 16 (8), 1728-1745, 2022 | 42 | 2022 |
| Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis HY Nam, DS Chandrashekar, A Kundu, S Shelar, EY Kho, G Sonpavde, ... Molecular Cancer Research, molcanres. 0636.2017, 2018 | 42 | 2018 |
| ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors H Rehman, DS Chandrashekar, C Balabhadrapatruni, S Nepal, ... JCI insight 7 (16), 2022 | 40 | 2022 |